Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Mason

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Postgraduate Medicine|April 1, 1978
The physician's office laboratory: how does yours measure up?C C Mason
Diabetologia|October 2, 2010
Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth studyD Dabelea, R B D'Agostino, C C Mason, et al.
Diabetologia|April 13, 2011
HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretionR C Williams, Y L Muller, R L Hanson, et al.
Leukemia|July 24, 2015
β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaA M Eiring, J S Khorashad, D J Anderson, et al.
Leukemia|December 10, 2015
Age-related mutations and chronic myelomonocytic leukemiaC C Mason, J S Khorashad, S K Tantravahi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Postgraduate Medicine|April 1, 1978
The physician's office laboratory: how does yours measure up?C C Mason
Diabetologia|October 2, 2010
Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth studyD Dabelea, R B D'Agostino, C C Mason, et al.
Diabetologia|April 13, 2011
HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretionR C Williams, Y L Muller, R L Hanson, et al.
Leukemia|July 24, 2015
β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemiaA M Eiring, J S Khorashad, D J Anderson, et al.
Leukemia|December 10, 2015
Age-related mutations and chronic myelomonocytic leukemiaC C Mason, J S Khorashad, S K Tantravahi, et al.
Pageof 1